CIK 0000874716
- Large accelerated filer
IDEXX LABORATORIES INC /DE
Sign in to watch- Ticker
- IDXX
- Exchange
- Nasdaq
- Industry
- In Vitro & In Vivo Diagnostic Substances
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 010393723
- Phone
- +1 207-556-0300
- Business address
- ONE IDEXX DRIVE, WESTBROOK, ME, 04092-2041
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $28,567,935
- in 5 filings
Net −$28,567,935. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- MAZELSKY JONATHAN JAY −$17.7M Executive Chair of the Board sold 23% of stake
- Underberg Sharon E. −$6.1M EVP, GC & Corporate Secretary sold 55% of stake
- Lane Michael −$2.7M Executive Vice President sold 49% of stake
- Kingsley Lawrence D −$1.2M Director sold 19% of stake
- JUNIUS DANIEL M −$845K Director sold 34% of stake
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +755 | $206.94 | $156K | 11,466.23 |
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +483 | $206.94 | $100K | 11,949.23 |
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +2,226 | $288.78 | $643K | 14,175.23 |
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Option exercise | +4,640 | $544.08 | $2.5M | 18,815.23 |
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Sale | −4,134 | $557.94 | $2.3M | 14,681.23 |
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Sale | −3,290 | $558.88 | $1.8M | 11,391.23 |
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Sale | −680 | $559.33 | $380K | 10,711.23 |
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −755 | 0 | ||
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Incentive Stock Option (right-to-buy) | −483 | 0 | ||
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −2,226 | 0 | ||
| 2024-03-06 | POLEWACZYK JAMES F Executive Vice President | Option exercise · Non-Qualified Stock Option (right-to-buy) | −4,640 | 1,363 | ||
| 2024-03-05 | Vandebroek Sophie V. Director | Option exercise | +1,404 | $245.79 | $345K | 2,620 |
| 2024-03-05 | Vandebroek Sophie V. Director | Sale | −1,404 | $562.98 | $790K | 1,216 |
| 2024-03-05 | Vandebroek Sophie V. Director | Option exercise · Non-Qualified Stock Option (right-to-buy) | −1,404 | 0 | ||
| 2024-02-29 | MAZELSKY JONATHAN JAY President and CEO | Gift | −550 | 81,496.59 | ||
| 2024-02-21 | MAZELSKY JONATHAN JAY President and CEO | Option exercise | +483 | $206.94 | $100K | 82,046.59 |
| 2024-02-21 | MAZELSKY JONATHAN JAY President and CEO | Option exercise · Incentive Stock Option (right-to-buy) | −483 | 0 | ||
| 2024-02-16 | Underberg Sharon E. EVP, GC & Corporate Secretary | Option exercise | +483 | $206.94 | $100K | 5,594.94 |
| 2024-02-16 | Underberg Sharon E. EVP, GC & Corporate Secretary | Option exercise · Incentive Stock Option (right-to-buy) | −483 | 0 | ||
| 2024-02-15 | MCKEON BRIAN P EVP, CFO and Treasurer | Option exercise | +483 | $206.94 | $100K | 30,834.59 |
Page 29 of 52 · 1,036 trades